Jiuyan Zhang

Marketing principle specialist @ WuXi Biologics

About

I am a science‑driven marketing professional currently working in the CRO Services Marketing team at WuXi Biologics, bringing together a strong multidisciplinary foundation across toxicology, molecular biology, veterinary medicine, and scientific communications.With a Master's degree in Clinical Veterinary Medicine, I gained solid expertise in molecular biology, CNS research, and both in vivo and in vitro study design, and published SCI papers (IF 20+), including a first‑author Q1 publication (IF >4).I began my career at Medicilon as a Safety Pharmacology Study Director, where over two years of leading GLP and non‑GLP studies strengthened my skills in toxicology study design, data interpretation, project management, and cross‑functional/client communication.I later joined a media company as an editor, gaining a broader view of the biopharma industry, sharpening my scientific storytelling, and developing a strong interest in marketing.Now, I focus on science‑grounded, high‑credibility marketing, turning complex scientific value into clear, impactful narratives that support business growth and help global biopharma clients understand CRO service capabilities.

Country

China

City

Shanghai

Industry

Pharmaceuticals

Skill

Design and Develop Visual Content, Cross‑functional Communication & Scientific Collaboration, Independent Toxicology/Safety Pharmacology Study Design & Execution, Project Management & Timeline Coordination

Experience

Marketing principle specialist

WuXi Biologics

2025-6 - Present · 1 yr 4 mos

Medical writer

上海图翎生物科技有限公司

2024-11 - 2025-4 · 6 mos

上海市, 中国

Tracked and analyzed the latest worldwide biopharma developments to extract emerging trends and actionable insights. Translated complex scientific and market information into clear, insight‑driven articles for a broad professional audience. Produced multiple high‑engagement pieces, including articles with 30,000+ individual views.

Study Director

Medicilon Inc.

2022-7 - 2024-10 · 2 yrs 4 mos

上海市, 中国

Led the design, execution, analysis, and reporting of 50+ GLP and non‑GLP safety pharmacology studies across small molecules, large molecules, and biologics. Conducted multi‑species system evaluations, including: CNS: FOB, Irwin test, rotarod, pole test Respiratory: whole‑body plethysmography in rodents Cardiovascular/Respiratory (large animals): DSI/EMKA telemetry in beagle dogs and cynomolgus monkeys Authored complete safety pharmacology modules and supported multiple programs through FDA and NMPA IND submissions, ensuring data integrity and GLP compliance. Established and enhanced in‑house platforms, including: Independently built the mouse rotarod testing platform Contributed to the development of the NHP FOB assessment platform Collaborated effectively across teams (pharmacology, toxicology, QA, PM) and with external clients, ensuring scientific clarity, efficient communication, and timely project delivery.